fk199b
Sleep Initiation and Maintenance Disorders
Astellas Pharma IncPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Sleep Initiation and Maintenance Disorders cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TENOFOVIR DISOPROXIL FUMARATE Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
(±)-FTC Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
ZOLPIDEM Astellas Pharma Inc | Phase 3 | BB |
Suvorexant Merck Sharp & Dohme LLC | Phase 3 | BB |
Modafinil VA Palo Alto Health Care System | Phase 4 | B |
View all 12 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →